[Juvenile malignant lymphomas. 2 Non-Hodgkin lymphomas]. 1981

F Zintl, and W Plenert, and D Stiller, and D Fuchs, and J Hermann, and W Ahlendorf, and H Schickedanz

Between 1970 and 1978 33 children with Non-Hodgkin-lymphomas at the age of 2-15 years were treated at the university children's hospital of Jena. 27 patients showed the first appearance of the disease, 6 patients had already been treated in other hospitals and were admitted with relapses. The biopsy material was classified or re-classified after the Kiel-classification. Beside the histological classification the surface markers of the malignant cells of NHL-patients were determined. 20 of 33 children were already in stage IV (Ann-Arbor-classification). Among our patients were 6 lymphoblastic NHL of Brukitt type, 10 of the convoluted cell type and 16 unclassified and one lymphoblastic lymphoma. The main localization of the NHL were mediastinum [15] and the gastrointestinal tract [10]. The therapy consisted of irradiation and chemotherapy (2 protocols) and, in case of an abdominal localization, in the attempt at a radical operation. Patients of stage I and stage II showed a complete remission rate of 50 per cent for 3 years; patients of stages III and IV of 20 per cent only. NHL of the convoluted cell type and of the Burkitt-type proved to have worse three-year-remission rates (16 per cent and 27 per cent) than unclassified lymphoblastic NHL (42 per cent).

UI MeSH Term Description Entries
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011867 Radioisotope Teletherapy A type of high-energy radiotherapy using a beam of gamma-radiation produced by a radioisotope source encapsulated within a teletherapy unit. Teleradioisotope Therapy,Teletherapy, Radioisotope,Therapy, Teleradioisotope
D012075 Remission, Spontaneous A spontaneous diminution or abatement of a disease over time, without formal treatment. Spontaneous Healing,Spontaneous Regression,Spontaneous Remission,Healing, Spontaneous,Regression, Spontaneous,Spontaneous Healings,Spontaneous Regressions
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003037 Cobalt Radioisotopes Unstable isotopes of cobalt that decay or disintegrate emitting radiation. Co atoms with atomic weights of 54-64, except 59, are radioactive cobalt isotopes. Radioisotopes, Cobalt
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271

Related Publications

F Zintl, and W Plenert, and D Stiller, and D Fuchs, and J Hermann, and W Ahlendorf, and H Schickedanz
May 1975, JFORL. Journal francais d'oto-rhino-laryngologie; audiophonologie et chirurgie maxillo-faciale,
F Zintl, and W Plenert, and D Stiller, and D Fuchs, and J Hermann, and W Ahlendorf, and H Schickedanz
September 1979, Orvosi hetilap,
F Zintl, and W Plenert, and D Stiller, and D Fuchs, and J Hermann, and W Ahlendorf, and H Schickedanz
January 1979, Soins; la revue de reference infirmiere,
F Zintl, and W Plenert, and D Stiller, and D Fuchs, and J Hermann, and W Ahlendorf, and H Schickedanz
November 1985, HNO,
F Zintl, and W Plenert, and D Stiller, and D Fuchs, and J Hermann, and W Ahlendorf, and H Schickedanz
October 1979, Journal francais d'oto-rhino-laryngologie; audiophonologie, chirurgie maxillo-faciale,
F Zintl, and W Plenert, and D Stiller, and D Fuchs, and J Hermann, and W Ahlendorf, and H Schickedanz
January 1984, Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna,
F Zintl, and W Plenert, and D Stiller, and D Fuchs, and J Hermann, and W Ahlendorf, and H Schickedanz
January 1981, Medicina clinica,
F Zintl, and W Plenert, and D Stiller, and D Fuchs, and J Hermann, and W Ahlendorf, and H Schickedanz
April 1981, Morphologiai es igazsagugyi orvosi szemle,
F Zintl, and W Plenert, and D Stiller, and D Fuchs, and J Hermann, and W Ahlendorf, and H Schickedanz
January 1987, Acta haematologica,
F Zintl, and W Plenert, and D Stiller, and D Fuchs, and J Hermann, and W Ahlendorf, and H Schickedanz
October 1980, MMW, Munchener medizinische Wochenschrift,
Copied contents to your clipboard!